Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $530.77 | 38 | 89.0% |
| Education | $65.35 | 2 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $102.98 | 8 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $70.75 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $68.39 | 2 | $0 (2017) |
| Amgen Inc. | $62.03 | 4 | $0 (2021) |
| Eisai Inc. | $43.79 | 3 | $0 (2018) |
| Allergan Inc. | $39.24 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $33.97 | 3 | $0 (2019) |
| Ultragenyx Pharmaceutical Inc. | $20.24 | 1 | $0 (2019) |
| Abbott Laboratories | $19.24 | 1 | $0 (2021) |
| DEXCOM, INC. | $17.24 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $167.40 | 11 | Amgen Inc. ($48.43) |
| 2019 | $147.86 | 10 | Janssen Pharmaceuticals, Inc ($58.53) |
| 2018 | $130.50 | 10 | Eisai Inc. ($43.79) |
| 2017 | $150.36 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($68.39) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes Care | ||||||
| 07/02/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Neuroscience | ||||||
| 06/22/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Obesity | ||||||
| 06/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/02/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neuroscience | ||||||
| 05/20/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Obesity | ||||||
| 05/06/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Neuroscience | ||||||
| 05/03/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Diabetes | ||||||
| 02/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2019 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Cranial Orthotic | ||||||
| 07/17/2019 | Ethicon US, LLC | LINX Reflux Management System (Device) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Endo-Mechanical | ||||||
| 06/14/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2019 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: XLH | ||||||
| 02/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2018 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: VACCINES | ||||||
| 11/29/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Obesity | ||||||
| 11/15/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 923 | 1,131 | $59,742 | $20,258 |
| 2020 | 14 | 2,382 | 3,121 | $148,285 | $57,229 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $8,836 | $5,953 | 67.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 170 | $20,230 | $4,599 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 81 | $14,013 | $3,769 | 26.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 619 | 779 | $12,464 | $3,753 | 30.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 12 | $3,285 | $1,883 | 57.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 11 | $418.00 | $171.82 | 41.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 28 | 31 | $496.00 | $129.87 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 145 | 145 | $27,260 | $16,053 | 58.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 1,647 | 2,240 | $35,840 | $13,772 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 206 | 307 | $36,533 | $8,322 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 132 | $22,836 | $6,230 | 27.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $3,675 | $2,472 | 67.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 17 | 17 | $4,505 | $2,391 | 53.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 47 | 49 | $5,530 | $2,297 | 41.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 33 | 33 | $2,970 | $2,012 | 67.8% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 24 | 26 | $2,626 | $1,010 | 38.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 12 | $2,196 | $867.29 | 39.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 36 | 36 | $1,368 | $562.01 | 41.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 19 | 21 | $1,220 | $545.67 | 44.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 58 | 63 | $1,008 | $403.26 | 40.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 17 | 17 | $646.00 | $264.30 | 40.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 11 | 12 | $72.00 | $26.90 | 37.4% |
About Dr. Del Burchell, MD
Dr. Del Burchell, MD is a Specialist healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619978418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Del Burchell, MD has received a total of $596.12 in payments from pharmaceutical and medical device companies, with $167.40 received in 2021. These payments were reported across 40 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($530.77).
As a Medicare-enrolled provider, Burchell has provided services to 3,305 Medicare beneficiaries, totaling 4,252 services with total Medicare billing of $77,487. Data is available for 2 years (2020–2021), covering 22 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Crestview Hills, KY
- Active Since 08/03/2005
- Last Updated 04/12/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1619978418
Products in Payments
- XARELTO (Drug) $70.75
- Aimovig (Biological) $48.43
- Belviq (Drug) $43.79
- Saxenda (Drug) $40.08
- JANUVIA (Drug) $33.97
- VRAYLAR (Drug) $31.44
- Victoza (Drug) $23.85
- Ozempic (Drug) $23.84
- CRYSVITA (Drug) $20.24
- FreeStyle Libre 2 (Device) $19.24
- DEXCOM G6 TRANSMITTER (Device) $17.24
- Doc Band (Device) $16.50
- Wegovy (Drug) $15.21
- SPIRIVA (Drug) $14.94
- LINX Reflux Management System (Device) $14.69
- Prolia (Biological) $13.60
- Mitigare (Drug) $12.67
- LINZESS (Drug) $12.44
- PREVNAR - 13 (Biological) $12.16
- ENTRESTO (Drug) $11.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Crestview Hills
Barry Wendt, Md, MD
Specialist — Payments: $4,013
Dr. Kara Shay, Md, MD
Specialist — Payments: $2,418
Dr. Glen Turner, Md, MD
Specialist — Payments: $943.99
Mark Meier, Md, MD
Specialist — Payments: $602.94
Terry Mcdannold, Md, MD
Specialist — Payments: $338.65
Dr. T Sommerkamp, M.d, M.D
Specialist